Evaluating Sedante Neo Therapy for Low Back Pain Relief
Effects of Sedante Neo Therapy on Pain, Range of Motion and Quality of Life in Patients With Non Specific Low Back Pain.
This study is testing if Sedante Neo therapy can help people with low back pain feel better and move more easily while improving their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 20 Weeks to 40 Weeks |
| Sex | All |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Lahore, Punjab Province) |
| Trial ID | NCT06987175 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of Sedante Neo therapy on pain, range of motion, and quality of life in patients suffering from non-specific low back pain. The research aims to provide insights that will assist physiotherapists in developing effective treatment plans. By focusing on a non-pharmacological approach, the study seeks to improve pain management outcomes while minimizing side effects. Participants will engage in Sedante Neo therapy alongside conventional exercises to assess overall effectiveness.
Who should consider this trial
Good fit: Ideal candidates are adults aged 20 to 40 with non-specific low back pain and specific pain and disability scores.
Not a fit: Patients outside the age range of 20 to 40 or those with specific exclusion criteria such as severe underlying conditions will not benefit.
Why it matters
Potential benefit: If successful, this therapy could offer a new, effective non-drug option for managing low back pain.
How similar studies have performed: While similar non-pharmacological approaches have shown promise, the specific efficacy of Sedante Neo therapy remains to be fully established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age group of 20 yeras to 40 years. * Both male and female included. * Having non-specific low back pain. * Having SF-MPQ score 1and 2 (1 means mild, 2 means moderate) * Having ODI score 5 to 24 * Having SF-36 healty survey score below 50 * Having range of motion below normal. Exclusion Criteria: * Below 20 years and above 40 years patient are excluded * Cervical, knee pain and other conditions excluded. * Children are excluded * Red flags ( tuberculosis, carcinoma heart disease etc) excluded -Open sores * Psychiatric diseases such as depression, phobias * Patient with history of surgery in lumber region
Where this trial is running
Lahore, Punjab Province
- Arthritis and pain care clinic Lahore. — Lahore, Punjab Province, Pakistan (Recruiting)
Study contacts
- Principal investigator: Ameena Amjad, Phd — Riphah International University
- Study coordinator: imran amjad, Phd
- Email: imran.amjad@riphah.edu.pk
- Phone: 03324390125
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.